Psychopharmacology and Psychiatry Updates cover image

Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD

Psychopharmacology and Psychiatry Updates

00:00

Intro

This chapter explores the alarming prevalence of alcohol use disorder in the U.S. and compares the effectiveness of naltrexone and topiramate as treatment options, while also considering genetic factors that may influence personalized recovery strategies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app